Provided by Tiger Trade Technology Pte. Ltd.

MannKind

3.90
+0.560016.77%
Post-market: 3.940.0400+1.03%18:54 EDT
Volume:15.00M
Turnover:56.88M
Market Cap:1.25B
PE:-27.86
High:4.03
Open:3.37
Low:3.30
Close:3.34
52wk High:6.51
52wk Low:2.23
Shares:321.54M
Float Shares:309.97M
Volume Ratio:3.92
T/O Rate:4.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1400
EPS(LYR):0.0200
ROE:32.74%
ROA:0.79%
PB:-18.66
PE(LYR):195.00

Loading ...

Liquidia ruling has positive read-through for MannKind Tyvaso DPI, says Truist

TIPRANKS
·
5 hours ago

H.C. Wainwright Keeps Their Buy Rating on MannKind (MNKD)

TIPRANKS
·
Sep 22

MannKind management to meet with Cantor

TIPRANKS
·
Sep 12

MannKind Price Target Maintained with a $8.00/Share by Cantor Fitzgerald

Dow Jones
·
Sep 11

Leerink Partners Sticks to Their Buy Rating for MannKind (MNKD)

TIPRANKS
·
Sep 10

MannKind Partners with Rose Pharma on Inhaled Rapid-Acting GLP-1 Weight-Loss Therapy

Reuters
·
Sep 09

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration Glp-1 for Weight Management

THOMSON REUTERS
·
Sep 09

MannKind Corporation: Specific Financial Terms of Agreement were not Disclosed

THOMSON REUTERS
·
Sep 09

MannKind Corporation - Rose Pharma Receives Exclusive Worldwide License for Technosphere Technology

THOMSON REUTERS
·
Sep 09

MannKind Corporation - to Provide Development and Manufacturing Support Through Phase 1B in Weight Management Study

THOMSON REUTERS
·
Sep 09

MannKind Corporation - to Receive Equity Interest in Rose Pharma and Potential Royalties on Future Net Sales

THOMSON REUTERS
·
Sep 09

MannKind Corporation - to Have Representation on Rose Pharma Board of Directors

THOMSON REUTERS
·
Sep 09

Wells Fargo Remains a Buy on MannKind (MNKD)

TIPRANKS
·
Sep 02

MannKind to Present at Upcoming Investor Conferences

GlobeNewswire
·
Sep 02

MannKind (MNKD) Stock May Be Fairly Priced After 27% Slide

Simply Wall St.
·
Aug 27

MannKind Corporation - Selling Stockholders May Offer up to 12,853,470 Shares Including 2,412,632 Warrant Shares - SEC Filing

THOMSON REUTERS
·
Aug 22

How MannKind’s (MNKD) Rising Revenue but Renewed Losses Could Reshape Its Growth Investment Story

Simply Wall St.
·
Aug 18

MannKind Director Steven B. Binder Sells 39,051 Shares Worth $158,547

Reuters
·
Aug 11

Is MannKind (MNKD) Undervalued After Positive INFLO 1 Data For Its IPF Pipeline?

Simply Wall St.
·
Aug 11

MannKind Posts Transcript of Q2 2026 Earnings Call

Reuters
·
Aug 07